discussing the latest results from the monaleesa-3 study
Published 6 years ago • 107 plays • Length 3:42Download video MP4
Download video MP3
Similar videos
-
3:09
overall survival results from monaleesa-3 study on ribociclib plus fulvestrant in advanced breas...
-
1:22
dr. slamon the phase iii results of monaleesa-3 trial in hr /her2- breast cancer
-
5:12
monaleesa-3: ribociclib plus fulvestrant in hr mbc
-
6:44
overall survival (os) results of the phase iii monaleesa-3 trial
-
4:03
discussing the latest data from the monaleesa-7 study
-
4:06
fda approves kisqali / ribociclib for early high-risk breast cancer esmo 2024
-
1:00:06
an algorithmic guide for clinical decision-making in hr , her2- ebc and mbc
-
3:51
kirwan rings the bell on final day of chemotherapy
-
17:54
expert perspectives: cdk 4/6 inhibitors for er breast cancer: current data and clinical use
-
13:53
gs2-01: "overall survival subgroup analysis by metastatic site from the phase3 monaleesa-2..."
-
2:55
practical implications of the monaleesa-3 trial
-
2:24
potential in the monaleesa-7 and monaleesa-3 trials
-
6:56
analyses from paloma-3 study, including os data for hr breast cancer
-
25:14
metastatic her2 negative breast cancer: emerging novel treatment strategies
-
10:15
monaleesa-3 os results: fulvestrant/ribociclib in postmenopausal hr /her2- advanced breast cancer
-
1:19
dr. slamon on os results of the monaleesa-3 trial in hr /her2- breast cancer
-
4:38
monarch 2: overall survival results from abermaciclib plus fulvestrant in hr her2- advanced bre...
-
2:27
results of the monaleesa-2 study in advanced breast cancer
-
10:02
expert perspectives: cdk 4/6 inhibitors for er breast cancer: emerging data and future implications
-
1:06
dr. neven on the design of the monaleesa-3 trial in advanced breast cancer
-
0:27
toxicities associated with ribociclib from monaleesa-3 trial
-
6:38
palbociclib in metastatic breast cancer. discussion of the paloma-2 results.